Other names: Journavc
Categories: Prescription Medication
Description:
Suzetrigine (Journavx) is a newly FDA-approved non-opioid pain medication for moderate-to-severe acute pain in adults. It works by blocking NaV1.8 sodium channels in the peripheral nervous system, reducing pain without addiction risk. Clinical trials show its efficacy is comparable to opioids, with fewer side effects like itching and muscle spasms. It is intended for short-term use only and offers a promising alternative to traditional pain management options.
Treatment For:
AI generated Summary: Based on the provided information, there is only one review for the treatment 'Suzetrigine' against 'Pain', but the review does not contain any content or rating. Due to the lack of sufficient data and user feedback, it is not possible to determine the effectiveness of this treatment for managing pain based on the given reviews and ratings.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
